Neurontin (gabapentin)
First released in the mid 1990’s by Parke-Davis, Neurontin is now sold by Pfizer. The FDA approved Neurontin for treatment of epileptic seizures. However, there is evidence that almost 80 percent of prescriptions written for Neurontin are for treatment of illnesses other than epilepsy and seizures. This practice, called “off-label” use, puts thousands of people at risk. People are exposed to Neurontin's many side effects for treatment of conditions that the drug has not been proven to alleviate.
- Bipolar Disorder
- Pain Syndromes, Peripheral Neuropathy, and Diabetic Neuropathy
- Amyotrophic Lateral Sclerosis (ALS), Lou Gehrig’s disease
- Reflex Sympathetic Dystrophy (RSD)
- Attention Deficit Disorder (ADD)
- Restless Leg Syndrome (RLS)
- Trigeminal Neuralgia
- Essential Tremor Periodic Limb Movement
- Migraine
- Drug and Alcohol Withdrawal Seizures
The United States Justice Department settled with Pfizer after a nearly two year
Neurontin, and other anticonvulsants, have been linked to an increase in suicidal behavior. Knowing this risk, the fact that Pfizer promoted Neurontin use for disorders it was not proven to help becomes even more infuriating.
If you or a loved one took Neurontin and suffered an injury, please contact a Neurontin attorney immediately to discuss your legal rights.
In the News:
Neurontin Lawsuit—Art of Deception, Legal News Watch